Guanrui Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guanrui Yang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Jahn Martin Nesland
Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway
3 shared publications - Zhenhe Suo
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
2 shared publications - Zhihui Wang
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Medical College of Zhengzhou University, Zhengzhou, China
2 shared publications - Baohua Zhang
Department of Human Anatomy, College of Basic Medical Science, Zhengzhou University, Zhengzhou 450001, Henan, P.R. China
1 shared publication - Claes Göran Tropé
Department of Gynecology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
1 shared publication - Gunhild Trøen
Division of Pathology, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
1 shared publication
Latest Publications
- Open Access
- 16 March 2012
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 23
GCS overexpression is associated with multidrug resistance of human HCT-8 colon cancer cells
Purpose: Multidrug resistance is one of the main impediments to the successful treatment of colon cancer. Glucosylceramide synthase (GCS) which is related to multidrug resistance (MDR) can reduce the level of ceramide and can help cells escape from the ceramide-induced cell apoptosis. However, the underlying mechanism is still unclear.Methods: The cell proliferation and cell toxicity were measured with Cell Counting Kit-8 (CCK-8). The mRNA levels of GCS and MDR1 were detected by semiquantitative reverse transcription-PCR amplification, the protein levels of GCS, caspase-3 and P-gp proteins were indicated by Western blotting. The apoptosis rates of cells were measured with flow cytometry.Results: The relative mRNA levels of GCS in HCT-8, HCT-8/VCR, HCT-8/VCR- sh-mock and HCT-8/VCR-sh-GCS were 71.4 ± 1.1%, 95.1 ± 1.2%, 98.2 ± 1.5%, and 66.6 ± 2.1% respectively. The mRNA levels of MDR1 were respectively 61.3 ± 1.1%, 90.5 ± 1.4%, 97.6 ± 2.2% and 56.1 ± 1.2%. The IC50 of Cisplatin complexes were respectively 69.070 ± 0.253 μg/ml, 312.050 ± 1.46 μg/ml, 328.741 ± 5.648 μg/ml, 150.792 ± 0.967 μg/ml in HCT-8, HCT-8/VCR, HCT-8/VCR-sh-mock and HCT-8/VCR-sh-GCS. The protein levels of caspase-3 were 34.2 ± o.6%, 93.0 ± 0.7%, 109.09 ± 0.7%, 42.7 ± 1.3% respectively. The apoptosis rates of cells were 8.77 ± 0.14%, 12.75 ± 0.54%, 15.39 ± 0.41% and 8.49 ± 0.23% respectively.Conclusion: In conclusion, our research indicated that suppression of GCS restores the sensitivity of multidrug resistance colon cancer cells to drug treatment.
- 16 March 2012
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 23
Open AccessGCS overexpression is associated with multidrug resistance of human HCT-8 colon cancer cells
Purpose: Multidrug resistance is one of the main impediments to the successful treatment of colon cancer. Glucosylceramide synthase (GCS) which is related to multidrug resistance (MDR) can reduce the level of ceramide and can help cells escape from the ceramide-induced cell apoptosis. However, the underlying mechanism is still unclear.Methods: The cell proliferation and cell toxicity were measured with Cell Counting Kit-8 (CCK-8). The mRNA levels of GCS and MDR1 were detected by semiquantitative reverse transcription-PCR amplification, the protein levels of GCS, caspase-3 and P-gp proteins were indicated by Western blotting. The apoptosis rates of cells were measured with flow cytometry.Results: The relative mRNA levels of GCS in HCT-8, HCT-8/VCR, HCT-8/VCR- sh-mock and HCT-8/VCR-sh-GCS were 71.4 ± 1.1%, 95.1 ± 1.2%, 98.2 ± 1.5%, and 66.6 ± 2.1% respectively. The mRNA levels of MDR1 were respectively 61.3 ± 1.1%, 90.5 ± 1.4%, 97.6 ± 2.2% and 56.1 ± 1.2%. The IC50 of Cisplatin complexes were respectively 69.070 ± 0.253 μg/ml, 312.050 ± 1.46 μg/ml, 328.741 ± 5.648 μg/ml, 150.792 ± 0.967 μg/ml in HCT-8, HCT-8/VCR, HCT-8/VCR-sh-mock and HCT-8/VCR-sh-GCS. The protein levels of caspase-3 were 34.2 ± o.6%, 93.0 ± 0.7%, 109.09 ± 0.7%, 42.7 ± 1.3% respectively. The apoptosis rates of cells were 8.77 ± 0.14%, 12.75 ± 0.54%, 15.39 ± 0.41% and 8.49 ± 0.23% respectively.Conclusion: In conclusion, our research indicated that suppression of GCS restores the sensitivity of multidrug resistance colon cancer cells to drug treatment.
- Open Access
- 5 July 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 352
Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
Background: Glutathione S-transferase pi (GST pi) is a subgroup of GST family, which provides cellular protection against free radical and carcinogenic compounds due to its detoxifying function. Expression patterns of GST pi have been studied in several carcinomas and its down-regulation was implicated to be involved in malignant transformation in patients with Barrett's esophagus. However, neither the exact role of GST pi in the pathogenesis nor its prognostic impact in squamous esophageal carcinoma is fully characterized.Methods: Immunohistochemistry was used to investigate GST pi expression on 153 archival squamous esophageal carcinoma specimens with a GST pi monoclonal antibody. Statistic analyses were performed to explore its association with clinicopathological factors and clinical outcome.Results: The GST pi expression was greatly reduced in tissues of esophageal carcinomas compared to adjacent normal tissues and residual benign tissues. Absent of GST pi protein expression in cytoplasm, nuclear and cytoplasm/nucleus was found in 51%, 64.7% and 48% of all the carcinoma cases, respectively. GST pi deficiency in cytoplasm, nucleus and cytoplasm/nucleus was significantly correlated to poor differentiation (p< 0.001,p< 0.001 andp< 0.001, respectively). UICC stage and T stage were found significantly correlated to negative expression of GST pi in cytoplasm (p< 0.001 andp= 0.004, respectively) and cytoplasm/nucleus (p= 0.017 andp= 0.031, respectively). In univariate analysis, absent of GST pi protein expression in cytoplasm, nucleus and cytoplasm/nucleus was significantly associated with a shorter overall survival (p< 0.001,p< 0.001 andp< 0.001, respectively), whereas only GST pi cytoplasmic staining retained an independent prognostic significance (p< 0.001) in multivariate analysis.Conclusions: Our results show that GST pi expression is down regulated in the squamous esophageal carcinoma, and that the lack of GST pi expression is associated with poor prognosis. Therefore, deficiency of GST pi protein expression may be an important mechanism involved in the carcinogenesis and progression of the squamous esophageal carcinoma, and the underlying mechanisms leading to decreased GST pi expression deserve further investigation.
- 5 July 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 352
Open AccessDecreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
Background: Glutathione S-transferase pi (GST pi) is a subgroup of GST family, which provides cellular protection against free radical and carcinogenic compounds due to its detoxifying function. Expression patterns of GST pi have been studied in several carcinomas and its down-regulation was implicated to be involved in malignant transformation in patients with Barrett's esophagus. However, neither the exact role of GST pi in the pathogenesis nor its prognostic impact in squamous esophageal carcinoma is fully characterized.Methods: Immunohistochemistry was used to investigate GST pi expression on 153 archival squamous esophageal carcinoma specimens with a GST pi monoclonal antibody. Statistic analyses were performed to explore its association with clinicopathological factors and clinical outcome.Results: The GST pi expression was greatly reduced in tissues of esophageal carcinomas compared to adjacent normal tissues and residual benign tissues. Absent of GST pi protein expression in cytoplasm, nuclear and cytoplasm/nucleus was found in 51%, 64.7% and 48% of all the carcinoma cases, respectively. GST pi deficiency in cytoplasm, nucleus and cytoplasm/nucleus was significantly correlated to poor differentiation (p< 0.001,p< 0.001 andp< 0.001, respectively). UICC stage and T stage were found significantly correlated to negative expression of GST pi in cytoplasm (p< 0.001 andp= 0.004, respectively) and cytoplasm/nucleus (p= 0.017 andp= 0.031, respectively). In univariate analysis, absent of GST pi protein expression in cytoplasm, nucleus and cytoplasm/nucleus was significantly associated with a shorter overall survival (p< 0.001,p< 0.001 andp< 0.001, respectively), whereas only GST pi cytoplasmic staining retained an independent prognostic significance (p< 0.001) in multivariate analysis.Conclusions: Our results show that GST pi expression is down regulated in the squamous esophageal carcinoma, and that the lack of GST pi expression is associated with poor prognosis. Therefore, deficiency of GST pi protein expression may be an important mechanism involved in the carcinogenesis and progression of the squamous esophageal carcinoma, and the underlying mechanisms leading to decreased GST pi expression deserve further investigation.
- Open Access
- 24 October 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 308
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
14-3-3 sigma (σ) promotes G2/M cell cycle arrest by sequestering cyclin B1-CDC2 complex in cytoplasm. Down-regulation of 14-3-3σ, which has been demonstrated in various carcinomas, may contribute to malignant transformation. However, the exact role of 14-3-3σ in the pathogenesis of vulvar carcinoma is not fully characterized, and the prognostic impact of 14-3-3σ protein expression is still unknown.
- 24 October 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 308
Open AccessThe clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
14-3-3 sigma (σ) promotes G2/M cell cycle arrest by sequestering cyclin B1-CDC2 complex in cytoplasm. Down-regulation of 14-3-3σ, which has been demonstrated in various carcinomas, may contribute to malignant transformation. However, the exact role of 14-3-3σ in the pathogenesis of vulvar carcinoma is not fully characterized, and the prognostic impact of 14-3-3σ protein expression is still unknown.
- Open Access
- 1 January 2006
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 14 (1) , 6-11
Effects of differentiation of human esophageal cancer cells on 5-aminolevulinic acid-induced endogenous protopophyrin IX production and photodynamic therapy
目的: 研究食管癌细胞的分化状态对ALA产生的内源性光敏剂PpIX累积水平的影响, 及对PDT的应答敏感程度. 方法: 以高分化食管鳞癌细胞KYSE-450和低分化食管鳞癌细胞KYSE-70为研究对象, 利用荧光分光光度法测定不同浓度ALA处理后细胞内PpIX的浓度; 分别使用不同剂量的红光和蓝光对细胞进行照射处理, MTS法测定PDT对细胞的光毒毒性; TdT-流式细胞法测定PDT诱导的凋亡水平, 并观察凋亡细胞的胞核形态. 结果: 高分化KYSE-450细胞比低分化KYSE-70细胞具有更强的PpIX合成或累积水平, 两者PpIX绝对浓度值在高于0.5 mmol/L ALA时差异显著(315.2±88.3 vs 156.9±79.2, P2(红光)和0.16 J/cm2(蓝光)时, 两者细胞存活率有极显著差异(88.0±7.4 vs 25.2±4.9, 红光; 97.4±7.3 vs 40.8±4.2, 蓝光; P结论: 食管鳞癌细胞的分化影响了内源性光敏剂PpIX的细胞内水平; PDT效应并不单纯依赖于细胞内的光敏剂含量, 细胞的生物学特征如分化状态也影响了PDT的效果; 高分化细胞部分通过抑制凋亡抵制了PDT作用.
- 1 January 2006
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 14 (1) , 6-11
Open AccessEffects of differentiation of human esophageal cancer cells on 5-aminolevulinic acid-induced endogenous protopophyrin IX production and photodynamic therapy
目的: 研究食管癌细胞的分化状态对ALA产生的内源性光敏剂PpIX累积水平的影响, 及对PDT的应答敏感程度. 方法: 以高分化食管鳞癌细胞KYSE-450和低分化食管鳞癌细胞KYSE-70为研究对象, 利用荧光分光光度法测定不同浓度ALA处理后细胞内PpIX的浓度; 分别使用不同剂量的红光和蓝光对细胞进行照射处理, MTS法测定PDT对细胞的光毒毒性; TdT-流式细胞法测定PDT诱导的凋亡水平, 并观察凋亡细胞的胞核形态. 结果: 高分化KYSE-450细胞比低分化KYSE-70细胞具有更强的PpIX合成或累积水平, 两者PpIX绝对浓度值在高于0.5 mmol/L ALA时差异显著(315.2±88.3 vs 156.9±79.2, P2(红光)和0.16 J/cm2(蓝光)时, 两者细胞存活率有极显著差异(88.0±7.4 vs 25.2±4.9, 红光; 97.4±7.3 vs 40.8±4.2, 蓝光; P结论: 食管鳞癌细胞的分化影响了内源性光敏剂PpIX的细胞内水平; PDT效应并不单纯依赖于细胞内的光敏剂含量, 细胞的生物学特征如分化状态也影响了PDT的效果; 高分化细胞部分通过抑制凋亡抵制了PDT作用.